Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001712368 | SCV000520128 | benign | not provided | 2018-04-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000757399 | SCV000764338 | benign | Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S | 2025-01-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000430376 | SCV000885602 | benign | not specified | 2018-08-09 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173366 | SCV001336454 | benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002418265 | SCV002717978 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001712368 | SCV005321495 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004551442 | SCV004745786 | benign | IGHMBP2-related disorder | 2019-05-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |